JAZZ vs RIME · P/E 1988, rev $2.28B vs rev $5.4M
Jazz Pharmaceuticals PLC (JAZZ) versus Algorhythm Holdings, Inc. (RIME) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Algorhythm Holdings, Inc. (RIME) is a consumer electronics company listed on NASDAQ.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported RIME revenue for 2026-06-30 was $5.4M. Net income was -$8.9M. RIME currently screens at market cap $11.6M.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. RIME currently screens at market cap $11.6M.
Not investment advice. Open the JAZZ and RIME stock pages for the full models.
Not investment advice.